The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease
Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care.
Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care.
The next wave of radiology AI value will come from closed-loop follow-up. An actionable finding should start a pathway with a measurable end state: the follow-up exam is completed, the referral is completed, or the recommendation is clinically resolved with a documented rationale.
Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control.
I lived for nine years with ALS while navigating a healthcare system that routinely obscured my own medical reality. But I know that pain is only amplified for individuals without medical expertise like mine.
Awareness of autism has grown, but we need to move beyond this into understanding and acceptance. Real progress depends on how we translate understanding into action — training more professionals, funding adult services, and redesigning workplaces and communities so autistic individuals can flourish throughout their lifespan.
Diagnosing PFAS can be challenging, but establishing a thorough symptom history along with specific IgE blood testing can build a fuller picture of patients’ allergic triggers and sensitizations, helping clinicians develop accurate, tailored treatment recommendations and ultimately improve their patients’ quality of life.
Symptoms often get labeled as anxiety, chronic fatigue, early neurodegeneration, IBS, or fibromyalgia. How to prevent the root cause — mold exposure — from going unrecognized.
As healthcare systems actively recalibrate their diagnostic strategies, evolved nasal lavage presents a safer, smarter specimen collection standard that results in more accurate and timely diagnosis plus more effective virus containment.
A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal.
Public debate is growing, but the real path forward lies in defining autism’s biology — and for the first time, we can.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care.
Transparent communication, sensitivity to parental concerns, and clear explanations of procedures help boost trust and reduce anxiety for both the patient and the provider.
Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority.
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis.